Ryan Fields

Medicine & Life Sciences

1. Survival 100%
2. Neuroendocrine Tumors 76%
3. Recurrence 59%
4. Neoplasms 58%
5. Adenocarcinoma 57%
6. Stomach Neoplasms 48%
7. Adrenocortical Carcinoma 43%
8. Neoplasm Metastasis 43%
9. Sarcoma 41%
10. Lymph Nodes 37%
11. Klatskin Tumor 35%
12. Stomach 34%
13. Gallbladder Neoplasms 32%
14. Pancreaticoduodenectomy 30%
15. Pancreatectomy 25%
16. Liver 22%
17. Databases 21%
18. Nomograms 20%
19. Melanoma 20%
20. Pancreatic Neoplasms 19%
21. Margins of Excision 18%
22. Cholangiocarcinoma 17%
23. Lymph Node Excision 16%
24. Merkel Cell Carcinoma 16%
25. Therapeutics 15%
26. Gastrectomy 13%
27. Drug Therapy 13%
28. Disease-Free Survival 13%
29. Extremities 13%
30. Radiotherapy 13%
31. Confidence Intervals 12%
32. Colorectal Neoplasms 11%
33. Mortality 11%
34. Pancreas 10%
35. Dendritic Cells 10%
36. Postoperative Complications 10%
37. Surgeons 10%
38. Blood Transfusion 9%
39. Macrophages 9%
40. Gastro-enteropancreatic neuroendocrine tumor 9%
41. Heterografts 9%
42. Hepatectomy 9%
43. Odds Ratio 9%
44. Incidence 8%
45. Length of Stay 8%
46. Propensity Score 8%
47. Gallbladder 8%
48. Morbidity 8%
49. antineoplaston A10 8%
50. Neutrophils 8%